Copyright: Jacobio Pharmaceuticals Co., Ltd.   Beijing ICP preparation 17065868-1   

 

百度地图API自定义地图

Address: Building F2, No. 88, Kechuang 6th Street, Beijing Economic Development Zone

Tel: +86  010-56315466

Fax: +86  010-56315314

E-mail: hr@jacobiopharma.com

 

 

关于我们

NEW

NEW

Jacobio's original innovative drug JAB-3312 obtained NMPA new drug clinical trial permission
First Patient Enrolled for Phase 1 Clinical Study of JAB-3312 in US
The Successfully Initiation of Phase I Clinical Trial of JAB-3312 - Jacobio’s Second Innovative Drug
JAB-3312, Jacobio’s Second Innovative Drug, has Obtained FDA’s Approval for Clinical Study
Jacobio's Innovative Drug Approved for Phase IIa Clinical Study in Multiple Solid Tumors and Awarded Orphan Drug Designation for the Treatment of Esophageal Cancer by US FDA
Page up
1
2